Robert Boldy
Internal Medicine · Apple Valley, CANPI 1063507382
Payments from drug & device makers
Across 76 payments — averaging $56.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$805
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$492
- Amgen$341
- Dexcom, Inc.$278
- Novo Nordisk$255
- Regeneron Healthcare Solutions, Inc.$250
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,305100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 30 | $805 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $492 |
| Amgen | 5 | $341 |
| Dexcom, Inc. | 2 | $278 |
| Novo Nordisk | 4 | $255 |
| Regeneron Healthcare Solutions, Inc. | 2 | $250 |
| Neurocrine Biosciences, Inc. | 2 | $249 |
| Merck | 2 | $217 |
| Boehringer Ingelheim | 2 | $153 |
| GSK | 2 | $147 |
| Hologic Sales And Service, LLC | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $125 |
| Intercept Pharmaceuticals, Inc. | 1 | $121 |
| AstraZeneca | 4 | $117 |
| Ironshore Pharmaceuticals Inc. | 2 | $114 |
| Biodelivery Sciences International, Inc. | 1 | $105 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Alkermes, Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $96 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Pfizer | 1 | $26 |
| Mannkind Corporation | 1 | $22 |
| AbbVie | 1 | $19 |
| Phadia US Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$278
- DUPIXENT$250
- INGREZZA$249
- STEGLATRO$217
- Repatha$125
- Cervical Cancer Screening$125
- Ozempic$125
- RYBELSUS$125
- Vascepa$125
- JARDIANCE$125
- TRELEGY ELLIPTA$125
- XIFAXAN$115
- Jornay PM 20mg capsules (Bottle of 100)$109
- BELBUCA$105
- LUCEMYRA$100
- TRULICITY$100
- TRULANCE$100
- TOUJEO$100
How this compares
$4,314 in reported general payments places this provider in the 85th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 28 | $580 |
| Hydrochlorothiazide | 17 | $133 |
| Amlodipine Besylate | 22 | $122 |
| Metformin Hcl | 12 | $115 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Apple Valley
- Andrew ChengSouth San Francisco$55.1M
- Joel NeutelTustin$34.9M
- Donald BrandonSan Diego$34M
- William TownerLos Angeles$27.4M
- Rahul AggarwalSan Francisco$24M
- Masoud AzizadNorthridge$21.1M
- Helen StaceyWalnut Creek$20.4M
- Rohit Loombala Jolla$15.1M
- Zeid KayaliColton$14.2M
- Alexandra DrakakiSanta Monica$14.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.